NCT04226846View on ClinicalTrials.gov

Feasibility Trial of the Bios Device for Continuous Glucose Monitoring

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Type 1 DiabetesType 2 Diabetes
Trial Locations (1)

94598

RECRUITING

Diablo Clinical Research, Inc, Walnut Creek

Sponsors
All Listed Sponsors
lead

GraphWear Technologies Inc.

INDUSTRY